Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-026451
Filing Date
2025-12-05
Accepted
2025-12-05 17:18:49
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A forms-3a.htm S-3/A 400676
2 EX-5.1 ex5-1.htm EX-5.1 23992
3 EX-23.1 ex23-1.htm EX-23.1 3728
4 GRAPHIC forms-3_001.jpg GRAPHIC 4601
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3070
  Complete submission text file 0001493152-25-026451.txt   440479
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-290580 | Film No.: 251553875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)